MediWound
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About MediWound
MediWound Ltd. 是一家生物製藥公司，開發、製造和商業化用於組織修復和再生的新型生物治療解決方案。它向燒傷中心和醫院燒傷單位銷售 NexoBrid，這是一種用於去除焦痂的生物製藥產品，焦痂是深度局部和全層熱燒傷成人的死亡或受損組織。該公司還開發了 EscharEx，該產品已完成用於清創慢性和其他難以癒合傷口的 II 期臨床試驗； MW005，用於治療低風險基底細胞癌的 I/II 期臨床試驗。 MediWound Ltd. 成立於 2000 年，總部位於以色列 Yavne。
如何購買 MediWound (MDWD)
登入
1分鐘開戶
僅需1分鐘即可完成帳戶申請和驗證。整個過程完全自助，支援 RockFlow App 和網頁端操作。
充值資金
帳戶驗證完成後，您可以使用首選的支付方式向帳戶充值。
購買 MDWD
透過 RockFlow App 或網頁端搜尋 MDWD，輸入您想要投資的金額，然後點擊確認即可完成交易。
Similar Stocks
© Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.